In: Journal of Molecular Medicine, 2015, vol. 93, no. 12, p. 1369-1379
|
In: Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, vol. 388, no. 12, p. 1283-1292
|
In: iScience, 2019, vol. 19, p. 39–53
Insulin-induced AKT activation is dependent on phosphoinositide 3-kinase and opposed by tumor suppressor phosphatase and tensin homolog (PTEN). Our previous study demonstrates that myosin 1b (MYO1B) mediates arginase-II-induced activation of mechanistic target of rapamycin complex 1 that is regulated by AKT. However, the role of MYO1B in AKT activation is unknown. Here we show that silencing...
|
In: European Journal of Applied Physiology, 2014, vol. 114, no. 2, p. 405-417
|
In: Journal of General Internal Medicine, 2014, vol. 29, no. 2, p. 356-356
|
In: Journal of Pediatric Endocrinology and Metabolism, 2015, vol. 28, no. 5-6, p. 539-544
|
In: BMC Genomics, 2010, vol. 11, no. 199, p. 1-19
Background: Tyrosine kinase 2 (Tyk2), a central component of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling, has major effects on innate immunity and inflammation. Mice lacking Tyk2 are resistant to endotoxin shock induced by lipopolysaccharide (LPS), and Tyk2 deficient macrophages fail to efficiently induce interferon alpha/beta after LPS treatment....
|
In: Cellular and Molecular Life Sciences, 2007, vol. 64, no. 24, p. 3261-3265
|
In: Diabetologia, 2004, vol. 47, no. 9, p. 1574-1580
|
In: Diabetologia, 2008, vol. 51, no. 8, p. 1457-1465
|